サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1511891

米国の遠隔患者モニタリングシステム市場規模、シェア、動向分析レポート：製品別、用途別、感染症別、最終用途別、セグメント予測、2024年～2030年

U.S. Remote Patient Monitoring System Market Size, Share & Trends Analysis Report By Product (Specialized Monitors), By Application, By Infections, By End-use, And Segment Forecasts, 2024 - 2030

出版日
ページ情報
英文 85 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
米国の遠隔患者モニタリングシステム市場規模、シェア、動向分析レポート：製品別、用途別、感染症別、最終用途別、セグメント予測、2024年～2030年
出版日: 2024年06月17日
発行: Grand View Research
ページ情報: 英文 85 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

米国の遠隔患者モニタリングシステム市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、米国の遠隔患者モニタリングシステム市場規模は2030年までに63億米ドルに達し、予測期間中にCAGR 18.4％で成長すると予測されています。

糖尿病、高血圧、心臓病などの慢性疾患の増加により、遠隔患者モニタリングシステムの需要が高まっています。これらのシステムは、慢性疾患をより効果的に管理し、入院を減らし、患者の転帰を改善するのに役立ちます。

米国のヘルスケアシステムは、より良い患者の転帰とコスト効率を重視する価値ベースのケアへと移行しています。遠隔患者モニタリングシステムは、ヘルスケアコストの削減と患者の転帰の改善に役立つため、このシフトに合致しています。遠隔患者監視システムは健康問題の早期発見を可能にし、タイムリーな介入とより良い予防医療を可能にします。このため、米国市場ではこうしたシステムの導入が増加しています。

米国疾病予防管理センター（CDC）によると、2021年には、高血圧が米国における69万1,095人の死亡の主な原因または主な原因の1つでした。糖尿病や高血圧などの慢性疾患の治療には、定期的な検査とモニタリングが必要であり、そのためにこれらの遠隔患者モニタリング装置が必要とされています。米国では糖尿病の患者数が増加しているため、これらの機器の需要が高まっています。

米国の遠隔患者モニタリングシステム市場レポート・ハイライト

  • 特殊モニターは、一般的な機器と比較して精度の高い特定のパラメータを持つため、2023年には80.0%以上のシェアを占めました。
  • バイタルサインモニター製品セグメントは予測期間中に最も速いCAGRで成長する見込み。
  • 糖尿病アプリケーションセグメントは、2023年に最大の市場シェアを占めました。糖尿病患者は、最適なコントロールを維持するために、1日に何度も血糖値をモニターする必要があることが多いです。
  • 副鼻腔感染症アプリケーションセグメントは、その合併症と、さらなる感染の診断と予防において遠隔患者モニタリングシステムが果たす重要な役割により、2023年に最大の市場シェアを占めました。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 米国の遠隔患者モニタリングシステム市場の変数、動向、範囲

  • 市場系統の見通し
    • 親市場の見通し
    • 関連/付随市場の見通し
  • 市場力学
    • 市場牽引要因分析
    • 市場抑制要因分析
  • 米国の遠隔患者モニタリングシステム市場分析ツール
    • 業界分析- ポーターのファイブフォース分析
    • PESTEL分析

第4章 米国の遠隔患者モニタリングシステム市場：製品の推定・動向分析

  • 市場シェア、2023年と2030年
  • セグメントダッシュボード
  • 製品別市場の見通し
  • 市場規模と予測および動向分析、2018年～2030年

第5章 米国の遠隔患者モニタリングシステム市場：用途の推定・動向分析

  • 市場シェア、2023年と2030年
  • セグメントダッシュボード
  • 用途別市場の見通し
  • 市場規模と予測および動向分析、2018年～2030年

第6章 米国の遠隔患者モニタリングシステム市場：感染の推定・動向分析

  • 市場シェア、2023年と2030年
  • セグメントダッシュボード
  • 感染別市場の見通し
  • 市場規模と予測および動向分析、2018年～2030年

第7章 米国の遠隔患者モニタリングシステム市場：最終用途の推定・動向分析

  • 市場シェア、2023年と2030年
  • セグメントダッシュボード
  • 最終用途別市場の見通し
  • 市場規模と予測および動向分析、2018年～2030年

第8章 競合情勢

  • 主要市場参入企業による最近の動向と影響分析
  • 企業/競合の分類
  • ベンダー情勢
  • 企業プロファイル
    • Welch Allyn
    • Smiths Medical
    • Abbott
    • Boston Scientific Corporation
    • Drager Medical
    • GE Healthcare
    • Honeywell
    • Johnson &Johnson
    • LifeWatch
    • Medtronic
図表

List of Tables

  • Table 1 List of abbreviations
  • Table 2 U.S. remote patient monitoring system market, by product, 2018 - 2030 (USD Million)
  • Table 3 U.S. remote patient monitoring system market, by infection, 2018 - 2030 (USD Million)
  • Table 4 U.S. remote patient monitoring system market, by application, 2018 - 2030 (USD Million)
  • Table 5 U.S. remote patient monitoring system market, by end-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 U.S. remote patient monitoring system market: Market outlook
  • Fig. 9 Remote patient monitoring system competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 U.S. remote patient monitoring system market driver impact
  • Fig. 14 U.S. remote patient monitoring system market restraint impact
  • Fig. 15 U.S. remote patient monitoring system market: Product movement analysis
  • Fig. 16 U.S. remote patient monitoring system market: Product outlook and key takeaways
  • Fig. 17 Vital sign monitors market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 18 Blood pressure monitors market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 19 Pulse oximeters market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 20 Heart rate monitor (ECG) market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 21 Temperature monitor market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 Respiratory rate monitor market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 Brain monitoring (EEG) market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 24 Specialized monitors market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 Anesthesia monitors market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Blood glucose monitors market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Cardiac rhythm monitor market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Respiratory monitor market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 Capnographs market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Spirometers market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 Fetal heart monitor market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 Prothrombin monitors market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Multi parameter monitors market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 U.S. remote patient monitoring system market: Application movement analysis
  • Fig. 36 U.S. remote patient monitoring system market: Application outlook and key takeaways
  • Fig. 37 Cancer market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Cardiovascular diseases market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Diabetes market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Sleep disorder market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Weight management and fitness monitoring market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Bronchitis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Infections market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Virus market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Dehydration market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Hypertension market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 U.S. remote patient monitoring system market: Infection movement Analysis
  • Fig. 48 U.S. remote patient monitoring system market: Infection outlook and key takeaways
  • Fig. 49 Eye infections market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Sinus infections market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Strep throat market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 U.S. remote patient monitoring system market: End-use movement analysis
  • Fig. 53 U.S. remote patient monitoring system market: End-use outlook and key takeaways
  • Fig. 54 Hospital-based patients market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Ambulatory patients market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Home healthcare market estimates and forecasts, 2018 - 2030 (USD Million)
目次
Product Code: GVR-4-68040-306-1

U.S. Remote Patient Monitoring System Market Growth & Trends:

The U.S. remote patient monitoring system market size is anticipated to reach USD 6.3 billion by 2030, growing at a CAGR of 18.4% during the forecast period, according to a new report by Grand View Research, Inc. The increasing incidence of chronic diseases, such as diabetes, hypertension, and heart diseases has led to a higher demand for remote patient monitoring systems. These systems help manage chronic conditions more effectively, reducing hospitalizations and improving patient outcomes.

The U.S. healthcare system is moving towards value-based care, which emphasizes better patient outcomes and cost efficiency. Remote patient monitoring systems align with this shift, as they help reduce healthcare costs and improve patient outcomes. Remote patient monitoring systems enable early detection of health issues, allowing for timely interventions and better preventive care. This has led to increased adoption of these systems in the U.S. market.

According to the Centers for Disease Control and Prevention (CDC), in 2021, hypertension was a primary or one of the major contributing causes of the 691,095 deaths in the U.S. The treatment of chronic diseases such as diabetes and hypertension require routine testing and monitoring, due to which, these remote patient monitoring devices are needed. The incensing cases of diabetes in the U.S., in turn, drives the demand of these devices.

U.S. Remote Patient Monitoring System Market Report Highlights:

  • Specialized monitors dominated the product segment with more than 80.0% share in 2023 owing to their specific parameters with greater accuracy compared to the general devices
  • The vital sign monitors product segment is expected to grow at the fastest CAGR over the forecast period
  • The diabetes application segment held the largest market share in 2023. Diabetic patients often need to monitor their blood glucose levels multiple times a day to maintain optimal control
  • The sinus infections application segment accounted for the largest market share in 2023, owing to their complications and significant role played by remote patient monitoring systems in diagnosing and preventing further infection

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Application
    • 1.2.3. Infection
    • 1.2.4. End-use
    • 1.2.5. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Volume price analysis (Model 2)
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product
    • 2.2.2. Application
    • 2.2.3. Infection
    • 2.2.4. End-use
  • 2.3. Competitive Insights

Chapter 3. U.S. Remote Patient Monitoring System Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Rising incidence of diseases such as diabetes
      • 3.2.1.2. Technological advancements in healthcare
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Stringent regulations & approvals
  • 3.3. U.S. Remote Patient Monitoring System Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. U.S. Remote Patient Monitoring System Market: Product Estimates & Trend Analysis

  • 4.1. Product Market Share, 2023 & 2030
  • 4.2. Segment Dashboard
  • 4.3. U.S. Remote Patient Monitoring System Market by Product Outlook
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
    • 4.4.1. Vital sign monitors
      • 4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.1.2. Blood pressure monitors
      • 4.4.1.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.1.3. Pulse oximeters
      • 4.4.1.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.1.4. Heart rate monitor (ECG)
      • 4.4.1.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.1.5. Temperature monitor
      • 4.4.1.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.1.6. Respiratory rate monitor
      • 4.4.1.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.1.7. Brain monitoring (EEG)
      • 4.4.1.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.2. Specialized monitors
      • 4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.2.2. Anesthesia monitors
      • 4.4.2.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.2.3. Blood glucose monitors
      • 4.4.2.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.2.4. Cardiac rhythm monitor
      • 4.4.2.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.2.5. Respiratory monitor
      • 4.4.2.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.2.6. Fetal heart monitors
      • 4.4.2.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.2.7. Prothrombin monitors
      • 4.4.2.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.2.8. Multi parameter monitors (MPM)
      • 4.4.2.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.2.9. Others (Ventilators, Infusion Pumps and others)
      • 4.4.2.9.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. U.S. Remote Patient Monitoring System Market: Application Estimates & Trend Analysis

  • 5.1. Application Market Share, 2023 & 2030
  • 5.2. Segment Dashboard
  • 5.3. U.S. Remote Patient Monitoring System Market by Application Outlook
  • 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
    • 5.4.1. Cancer
      • 5.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.2. Cardiovascular diseases
      • 5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.3. Diabetes
      • 5.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.4. Sleep disorder
      • 5.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.5. Weight management and fitness monitoring
      • 5.4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.6. Bronchitis
      • 5.4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.7. Infections
      • 5.4.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.8. Virus
      • 5.4.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.9. Dehydration
      • 5.4.9.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.10. Hypertension
      • 5.4.10.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. U.S. Remote Patient Monitoring System Market: Infection Estimates & Trend Analysis

  • 6.1. Infection Market Share, 2023 & 2030
  • 6.2. Segment Dashboard
  • 6.3. U.S. Remote Patient Monitoring System Market by Infection Outlook
  • 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
    • 6.4.1. Eye infections
      • 6.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.2. Sinus infections
      • 6.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.3. Strep throat
      • 6.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. U.S. Remote Patient Monitoring System Market: End-use Estimates & Trend Analysis

  • 7.1. End-use Market Share, 2023 & 2030
  • 7.2. Segment Dashboard
  • 7.3. U.S. Remote Patient Monitoring System Market by End-use Outlook
  • 7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
    • 7.4.1. Hospital-based patients
      • 7.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.2. Ambulatory patients
      • 7.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.3. Home healthcare
      • 7.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company/Competition Categorization
  • 8.3. Vendor Landscape
    • 8.3.1. List of key distributors and channel partners
    • 8.3.2. Key customers
    • 8.3.3. Key company heat map analysis, 2023
  • 8.4. Company Profiles
    • 8.4.1. Welch Allyn
      • 8.4.1.1. Company overview
      • 8.4.1.2. Financial performance
      • 8.4.1.3. Product benchmarking
      • 8.4.1.4. Strategic initiatives
    • 8.4.2. Smiths Medical
      • 8.4.2.1. Company overview
      • 8.4.2.2. Financial performance
      • 8.4.2.3. Product benchmarking
      • 8.4.2.4. Strategic initiatives
    • 8.4.3. Abbott
      • 8.4.3.1. Company overview
      • 8.4.3.2. Financial performance
      • 8.4.3.3. Product benchmarking
      • 8.4.3.4. Strategic initiatives
    • 8.4.4. Boston Scientific Corporation
      • 8.4.4.1. Company overview
      • 8.4.4.2. Financial performance
      • 8.4.4.3. Product benchmarking
      • 8.4.4.4. Strategic initiatives
    • 8.4.5. Drager Medical
      • 8.4.5.1. Company overview
      • 8.4.5.2. Financial performance
      • 8.4.5.3. Product benchmarking
      • 8.4.5.4. Strategic initiatives
    • 8.4.6. GE Healthcare
      • 8.4.6.1. Company overview
      • 8.4.6.2. Financial performance
      • 8.4.6.3. Product benchmarking
      • 8.4.6.4. Strategic initiatives
    • 8.4.7. Honeywell
      • 8.4.7.1. Company overview
      • 8.4.7.2. Financial performance
      • 8.4.7.3. Product benchmarking
      • 8.4.7.4. Strategic initiatives
    • 8.4.8. Johnson & Johnson
      • 8.4.8.1. Company overview
      • 8.4.8.2. Financial performance
      • 8.4.8.3. Product benchmarking
      • 8.4.8.4. Strategic initiatives
    • 8.4.9. LifeWatch
      • 8.4.9.1. Company overview
      • 8.4.9.2. Financial performance
      • 8.4.9.3. Product benchmarking
      • 8.4.9.4. Strategic initiatives
    • 8.4.10. Medtronic
      • 8.4.10.1. Company overview
      • 8.4.10.2. Financial performance
      • 8.4.10.3. Product benchmarking
      • 8.4.10.4. Strategic initiatives